Accession Number: | 0001209191-21-040466 |
Date: | 2021-06-11 |
Issuer: | BIOLASE, INC (BIOL) |
Original Submission Date: |
DITOLLA MICHAEL
27042 TOWNE CENTRE DR.
SUITE 270
FOOTHILL RANCH, CA 92610
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK APPRECIATION RIGHT | 0.84 | 2021-06-11 | deemed execution date | A | 104,603 (a) | 2031-06-11 | common stock 104,603 | $0.84 | 104,603 | direct | ||
RESTRICTED STOCK UNIT | 0.0 | 2021-06-11 | deemed execution date | A | 110,400 (a) | common stock 110,400 | $0.00 | 110,400 | direct |
ID | footnote |
---|---|
f1 | of the stock appreciation rights subject to this sar, one-fourth of the stock appreciation rights vest on each of the third, sixth, ninth, and twelfth-month anniversaries of the date of grant. |
f2 | at the option of the company, each restricted stock unit represents the right to receive, at settlement, one share of common stock, or its cash equivalent. |
f3 | the restricted stock unit award fully vests and is immediately exercisable upon the filing with the sec of the annual report on form 10-k for the year ending december 31, 2023. |